Use of a novel adjunctive clinical trial design to examine efficacy, safety, and improved generalizability of armodafinil for the treatment of bipolar I depression 10th International Conference on Bipolar Disorder of the International-Society-for-Bipolar-Disorders Calabrese, J. R., Frye, M. A., Yang, R., Ketter, T. A. WILEY-BLACKWELL. 2013: 59–59

View details for Web of Science ID 000319826800129